MX2009006889A - Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. - Google Patents
Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa.Info
- Publication number
- MX2009006889A MX2009006889A MX2009006889A MX2009006889A MX2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A MX 2009006889 A MX2009006889 A MX 2009006889A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- methods
- cannabinoid
- combination
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 102000012440 Acetylcholinesterase Human genes 0.000 title 1
- 108010022752 Acetylcholinesterase Proteins 0.000 title 1
- 229940022698 acetylcholinesterase Drugs 0.000 title 1
- 230000008485 antagonism Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 208000011117 substance-related disease Diseases 0.000 abstract 3
- 206010013663 drug dependence Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010048650 Cholinesterase inhibition Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000030886 Traumatic Brain injury Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000009032 substance abuse Diseases 0.000 abstract 1
- 231100000736 substance abuse Toxicity 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000009529 traumatic brain injury Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06126584 | 2006-12-20 | ||
| PCT/EP2007/064169 WO2008074816A1 (en) | 2006-12-20 | 2007-12-19 | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006889A true MX2009006889A (es) | 2009-07-07 |
Family
ID=38024247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006889A MX2009006889A (es) | 2006-12-20 | 2007-12-19 | Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. |
Country Status (7)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102802332B1 (ko) * | 2020-07-14 | 2025-05-07 | 주식회사 리스큐어바이오사이언시스 | 페디오코쿠스 이노피나투스 또는 이로부터 유래된 세포밖 소포체를 유효성분으로 포함하는 뇌질환의 치료용 조성물 |
| WO2022089598A1 (zh) * | 2020-10-30 | 2022-05-05 | 杭州拉林智能科技有限公司 | 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用 |
-
2007
- 2007-12-17 TW TW96148210A patent/TW200843772A/zh unknown
- 2007-12-17 AR ARP070105654 patent/AR064379A1/es not_active Application Discontinuation
- 2007-12-19 BR BRPI0721060-4A patent/BRPI0721060A2/pt not_active IP Right Cessation
- 2007-12-19 MX MX2009006889A patent/MX2009006889A/es unknown
- 2007-12-19 CN CN200780047166A patent/CN101848907A/zh active Pending
- 2007-12-19 IN IN3566CHN2009 patent/IN2009CN03566A/en unknown
-
2009
- 2009-05-29 ZA ZA200903779A patent/ZA200903779B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101848907A (zh) | 2010-09-29 |
| AR064379A1 (es) | 2009-04-01 |
| BRPI0721060A2 (pt) | 2014-02-25 |
| ZA200903779B (en) | 2010-04-28 |
| TW200843772A (en) | 2008-11-16 |
| IN2009CN03566A (enrdf_load_stackoverflow) | 2015-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL198926A0 (en) | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition | |
| UA94660C2 (en) | Amino-heterocyclic compounds | |
| TW200745135A (en) | Therapeutic agents | |
| RS20060129A (en) | /1,8/naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| MXPA06011194A (es) | Tiadiazolidinonas como inhibidores de gsk-3. | |
| CU20110106A7 (es) | Nuevos compuestos 578 | |
| TW200531689A (en) | Therapeutic agents | |
| ATE455763T1 (de) | Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit | |
| IL176546A0 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
| MY155318A (en) | Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists | |
| MX2009003183A (es) | Derivados de sulfonilpirazolincarboxamidina como antagonistas de 5-ht6. | |
| MX2009005509A (es) | 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a). | |
| UA100232C2 (uk) | Кристалічні форми інгібітора glyt1 | |
| EP2416795A4 (en) | COGNITIVE DECLINE INHIBITORS | |
| TW200633957A (en) | Compounds | |
| TW200734324A (en) | Therapeutic agents | |
| TW200635589A (en) | Therapeutic agents | |
| MX2009006889A (es) | Compuestos con una combinacion de antagonismo de cannabinoide-receptor cannabinoide subtipo 1 e inhibicion de acetilcolinesterasa. | |
| GB0428232D0 (en) | Compounds | |
| MX2009007405A (es) | Compuestos con una combinacion de antagonismo de cb1 cannabinoide e inhibicion de recaptacion de serotonina. | |
| RS20080139A (en) | Imidazole coumpounds for the treatment of neurological disorders | |
| MY136718A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| WO2008102888A1 (ja) | 新規擬似糖脂質及びその用途 | |
| TW200633956A (en) | Compounds | |
| WO2005095348A3 (en) | Pyrazole-amine compounds for the treatment of neurodegenerative disorders |